Literature DB >> 8083659

Varicella-zoster virus antibody avidity and IgG-subclass patterns in children with recurrent chickenpox.

A K Junker1, P Tilley.   

Abstract

The normal immune response after primary varicella-zoster virus (VZV) infection includes IgG subclass evolution to predominantly IgG1-type antibodies, and maturation from low to high avidity antibodies which are maintained for life. Twenty-three healthy and apparently immunocompetent children with a history of 2-5 episodes of chickenpox were studied after repeat disease. Serial sera were tested for VZV-IgG subclass patterns and VZV IgG and G-subclass antibody avidity by urea elution enzyme linked immunoassay (ELISA). Of 11 patients studied within 8 weeks of repeat chickenpox (Early Group), mean antibody avidity was significantly lower (31.3 +/- 26.81) than control (65.1 +/- 12.38) (P < .001). Seven had low avidity antibody (< 30 percent) and an abundance of IgG3 which was a pattern like primary chickenpox, and 2/11 had high avidity antibody characteristic of anamnestic responses. Early Group patients and 12 others studied over 8 weeks after repeat disease (Late Group) showed avidity maturation and attrition of IgG subclass antibodies other than IgG1. At least nine children failed to show VZV-specific secondary (memory) immune responses early in the course of repeat disease. It is possible that failure to maintain or evoke a secondary immune response could explain their susceptibility to repeat chickenpox.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8083659     DOI: 10.1002/jmv.1890430204

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  15 in total

1.  B-cell epitopes of varicella-zoster virus glycoprotein II.

Authors:  A Kjartansdóttir; E Lycke; S R Norrby
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

2.  Evolution of envelope-specific antibody responses in monkeys experimentally infected or immunized with simian immunodeficiency virus and its association with the development of protective immunity.

Authors:  K S Cole; J L Rowles; B A Jagerski; M Murphey-Corb; T Unangst; J E Clements; J Robinson; M S Wyand; R C Desrosiers; R C Montelaro
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

3.  Differentiation of primary from nonprimary genital herpes infections by a herpes simplex virus-specific immunoglobulin G avidity assay.

Authors:  M Hashido; S Inouye; T Kawana
Journal:  J Clin Microbiol       Date:  1997-07       Impact factor: 5.948

4.  Use of an anti-hepatitis C virus (HCV) IgG avidity assay to identify recent HCV infection.

Authors:  Catherine Gaudy-Graffin; Gérard Lesage; Isabelle Kousignian; Syria Laperche; Annie Girault; Frédéric Dubois; Alain Goudeau; Francis Barin
Journal:  J Clin Microbiol       Date:  2010-07-07       Impact factor: 5.948

5.  Diagnostic relevance of immunoglobulin G avidity for hepatitis A virus.

Authors:  Anne-Marie Roque-Afonso; Liliane Grangeot-Keros; Bénédicte Roquebert; Delphine Desbois; Jean-Dominique Poveda; Vincent Mackiewicz; Elisabeth Dussaix
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

6.  Serum antibody responses in children with rotavirus diarrhea can serve as proxy for protection.

Authors:  J Xu; P Dennehy; H Keyserling; L E Westerman; Y Wang; R C Holman; J R Gentsch; R I Glass; B Jiang
Journal:  Clin Diagn Lab Immunol       Date:  2005-02

Review 7.  Pathogenesis and current approaches to control of varicella-zoster virus infections.

Authors:  Anne A Gershon; Michael D Gershon
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

Review 8.  Microbiology laboratory and the management of mother-child varicella-zoster virus infection.

Authors:  Massimo De Paschale; Pierangelo Clerici
Journal:  World J Virol       Date:  2016-08-12

9.  Relationship between herpes simplex virus-1-specific antibody titers and cortical brain damage in Alzheimer's disease and amnestic mild cognitive impairment.

Authors:  Roberta Mancuso; Francesca Baglio; Simone Agostini; Monia Cabinio; Maria M Laganà; Ambra Hernis; Nicolò Margaritella; Franca R Guerini; Milena Zanzottera; Raffaello Nemni; Mario Clerici
Journal:  Front Aging Neurosci       Date:  2014-10-15       Impact factor: 5.750

10.  A new method for determination of varicella-zoster virus immunoglobulin G avidity in serum and cerebrospinal fluid.

Authors:  Ralf-Herbert Kneitz; Jörg Schubert; Franz Tollmann; Wolfgang Zens; Klaus Hedman; Benedikt Weissbrich
Journal:  BMC Infect Dis       Date:  2004-09-08       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.